In the BioHarmony Drug Report Database

"Preview" Icon

Leuprolide

Eligard, Fensolvi, Lupron, Lupron Depot, Lupron Depot-ped, Lutrate Depot, Viadur (leuprolide) is a protein pharmaceutical. Leuprolide was first approved as Eligard on 1985-04-09. It is used to treat breast neoplasms, endometrial neoplasms, endometriosis, infertility, and leiomyoma amongst others in the USA. The pharmaceutical is active against gonadotropin-releasing hormone receptor. Lupron depot’s patents are valid until 2031-02-05 (FDA).

 

Trade Name

 

Eligard, Fensolvi, Lupron, Lupron Depot, Lupron Depot-ped, Lutrate Depot, Viadur
 

Common Name

 

leuprolide
 

ChEMBL ID

 

CHEMBL1201199
 

Indication

 

breast neoplasms, endometrial neoplasms, endometriosis, infertility, leiomyoma, ovarian neoplasms, precocious puberty, prostatic hyperplasia, prostatic neoplasms
 

Drug Class

 

Gnrh analogue; GnRH agonist; Antigonadotropin

Image (chem structure or protein)

Leuprolide structure rendering